(Q42830394)

8 November 2017

title

Inhibition of MMP-13 prevents diet-induced obesity in mice and suppresses adipogenesis in 3T3-L1 preadipocytes (English)

1 reference

8 November 2017

1 reference

2

Kolapo M Ajuwon

1 reference

8 November 2017

Chia-Li M Shih

1

1 reference

8 November 2017

publication date

15 February 2015

1 reference

Molecular Biology Reports

8 November 2017

published in

1 reference

8 November 2017

volume

42

1 reference

8 November 2017

issue

7

1 reference

8 November 2017

page(s)

1225-1232

1 reference

Abdominal obesity and metabolic syndrome

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Effect of tissue inhibitor of matrix metalloproteinases-1 on in vitro and in vivo adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Biochemical characterization of human collagenase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

A pericellular collagenase directs the 3-dimensional development of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

PPARgamma in adipocyte differentiation and metabolism--novel insights from genome-wide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Adipogenic histone mark regulation by matrix metalloproteinase 14 in collagen-rich microenvironments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Adipocyte size predicts incidence of type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-015-3861-2

Matrix metalloproteinase inhibition impairs adipose tissue development in mice

21 January 2018

1 reference

12 December 2020

A functional role of gelatinase A in the development of nutritionally induced obesity in mice

1 reference

12 December 2020

Role of proteolysis in development of murine adipose tissue

1 reference

12 December 2020

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

1 reference

12 December 2020

Adipose tissue expression of gelatinases in mouse models of obesity

1 reference

12 December 2020

10.1007/S11033-015-3861-2

Identifiers

DOI

1 reference

8 November 2017

1 reference